Aberrant production of soluble inducible Tcell costimulator (sICOS) and soluble programmed cell death protein 1 (sPD1) in patients with chronic hepatitis C

By                              

Molecular Medicine Reports, Vol. 7, Iss. 4, 2013-01 ,pp. : 1197-1202

Spandidos Publications

Access to resources Recommend Favorite

Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 2, 2016-04 ,pp. : 141-151

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammation promotes oral squamous carcinoma immune evasion via induced programmed death ligand1 surface expression

By                    

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1519-1526

Spandidos Publications

Access to resources Recommend Favorite

Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer

By Maine Christian   Aziz Nor   Chatterjee Jayanta   Hayford Claudia   Brewig Nancy   Whilding Lynsey   George Andrew   Ghaem-Maghami Sadaf  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 3, 2014-03 ,pp. : 215-224

Springer Publishing Company

Access to resources Recommend Favorite

Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinoma

By              

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 90-96

Spandidos Publications

Access to resources Recommend Favorite